Motohashi H - Search Results

1

Is gastric carcinoma different between Japan and the United States?

Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Noguchi Y, et al. Among authors: motohashi h. Cancer. 2000 Dec 1;89(11):2237-46. Cancer. 2000. PMID: 11147594

2

[Clinical significance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in peripheral blood of patients with gastric carcinoma].

Yoshikawa T, Suzuki K, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y, Tsuburaya A. Yoshikawa T, et al. Among authors: motohashi h. Gan To Kagaku Ryoho. 1998 Jul;25(9):1461-4. Gan To Kagaku Ryoho. 1998. PMID: 9703854 Japanese.

3

Thymidine phosphorylase/platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancer.

Yoshikawa T, Suzuki K, Kobayashi O, Sairenji M, Motohashi H, Tsuburaya A, Nakamura Y, Shimizu A, Yanoma S, Noguchi Y. Yoshikawa T, et al. Among authors: motohashi h. Br J Cancer. 1999 Mar;79(7-8):1145-50. doi: 10.1038/sj.bjc.6690182. Br J Cancer. 1999. PMID: 10098749 Free PMC article.

4

Tissue inhibitor of matrix metalloproteinase-1 in the plasma of patients with gastric carcinoma. A possible marker for serosal invasion and metastasis.

Yoshikawa T, Saitoh M, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y. Yoshikawa T, et al. Among authors: motohashi h. Cancer. 1999 Nov 15;86(10):1929-35. doi: 10.1002/(sici)1097-0142(19991115)86:10<1929::aid-cncr8>3.0.co;2-c. Cancer. 1999. PMID: 10570415

5

Prognostic value of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with gastric cancer.

Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y. Yoshikawa T, et al. Among authors: motohashi h. Cancer Lett. 2000 Apr 3;151(1):81-6. doi: 10.1016/s0304-3835(99)00420-6. Cancer Lett. 2000. PMID: 10766426

6

Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma.

Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y. Yoshikawa T, et al. Among authors: motohashi h. Cancer Lett. 2000 May 29;153(1-2):7-12. doi: 10.1016/s0304-3835(99)00426-7. Cancer Lett. 2000. PMID: 10779624

7

Neoadjuvant chemotherapy with a combination of irinotecan and cisplatin in advanced gastric cancer--a case report.

Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Kameda Y, Noguchi Y. Yoshikawa T, et al. Among authors: motohashi h. Hepatogastroenterology. 2000 Nov-Dec;47(36):1575-8. Hepatogastroenterology. 2000. PMID: 11149004

8

Intratumoral concentrations of tissue inhibitor of matrix metalloproteinase 1 in patients with gastric carcinoma a new biomartker for invasion and its impact on survival.

Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y. Yoshikawa T, et al. Among authors: motohashi h. Cancer. 2001 May 1;91(9):1739-44. doi: 10.1002/1097-0142(20010501)91:9<1739::aid-cncr1192>3.0.co;2-9. Cancer. 2001. PMID: 11335899

9

[Significance of laparoscopy for response assessment of chemotherapy in gastric cancer].

Kobayashi O, Kanari M, Yoshikawa T, Tsuburaya A, Sairenji M, Motohashi H. Kobayashi O, et al. Among authors: motohashi h. Gan To Kagaku Ryoho. 2001 Aug;28(8):1141-4. Gan To Kagaku Ryoho. 2001. PMID: 11525033 Japanese.

10

Should scirrhous gastric carcinoma be treated surgically? Clinical experiences with 233 cases and a retrospective analysis of prognosticators.

Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Noguchi Y. Yoshikawa T, et al. Among authors: motohashi h. Hepatogastroenterology. 2001 Sep-Oct;48(41):1509-12. Hepatogastroenterology. 2001. PMID: 11677997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters